Characterizing exons 11 and 1 promoters of the mu opioid receptor (Oprm) gene in transgenic mice

BMC Molecular Biology

Volumn 7, Issue , 2006, Pages

  Xu, Jin ^a   Xu, Mingming ^a   Pan, Ying Xian ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA GALACTOSIDASE; MESSENGER RNA; MU OPIATE RECEPTOR; TATA BINDING PROTEIN; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EUKARYOTE; EXON; FEMALE; GENE CONSTRUCT; GENE EXPRESSION; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMUNOREACTIVITY; IN VIVO STUDY; LONG TERM CARE; MALE; MOUSE; NONHUMAN; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA; TATA BOX; TRANSGENIC MOUSE;

ANIMALS; BLOTTING, SOUTHERN; CENTRAL NERVOUS SYSTEM; EXONS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; MODELS, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTORS, OPIOID, MU; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TAU PROTEINS;

EUKARYOTA; MUS MUSCULUS;

EID: 33845220086     PISSN: 14712199     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-7-41     Document Type: Article

References (65)

1. Pasternak GW: Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 1993, 16:1-18.
2. Inturrisi CE, Schultz M, Shin S, Umans JG, Angel L, Simon EJ: Evidence from opiate binding sites that heroin acts through its metabolites. Life Sci 1983, 3:773-776.
3. Wolozin BL, Pasternak GW: Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc Natl Acad Sci U S A 1981, 78:6181-6185.
4. Pasternak GW, Standifer KM: Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. Trends Pharmacol Sci 1995, 16:344-350.
5. Rossi GC, Pan YX, Brown GP, Pasternak GW: Antisense Mapping the Mor-1 Opioid Receptor - Evidence for Alternative Splicing and A Novel Morphine-6-Beta-Glucuronide Receptor. FEBS Lett 1995, 369:192-196.
6. Chen Y, Mestek A, Liu J, Hurley JA, Yu L: Molecular cloning and functional expression of a m-opioid receptor from rat brain. Mol Pharmacol 1993, 44:8-12.
7. Liang Y, Mestek A, Yu L, Carr LG: Cloning and characterization of the promoter region of the mouse m opioid receptor gene. Brain Res 1995, 679:82-88.
8. Min BH, Augustin LB, Felsheim RF, Fuchs JA, Loh HH: Genomic structure and analysis of promoter sequence of a mouse m opioid receptor gene. Proc Natl Acad Sci USA 1994, 91:9081-9085.
9. Wendel B, Hoehe MR: The human m opioid receptor gene: 5′ regulatory and intronic sequences. J Mol Med 1998, 76:525-532.
10. Bare LA, Mansson E, Yang D: Expression of two variants of the human m opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett 1994, 354:213-216.
11. Zimprich A, Simon T, Hollt V: Cloning and expression of an isoform of the rat m opioid receptor (rMOR I B) which differs in agonist induced desensitization from rMORI. FEBS Lett 1995, 359:142-146.
12. Pan YX, Xu J, Bolan EA, Abbadie C, Chang A, Zuckerman A, Rossi GC, Pasternak GW: Identification and characterization of three new alternatively spliced mu opioid receptor isoforms. Mol Pharmacol 1999, 56:396-403.
13. Pan YX, Xu J, Bolan E, Chang A, Mahurter L, Rossi G, Pasternak GW: Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-IF. FEBS Lett 2000, 466:337-340.
14. Pan YX, Xu J, Mahurter L, Bolan E, Xu M, Pasternak GW: Generation of the mu opioid receptor (MOR-i) protein by three new splice variants of the Oprm gene. Proc Natl Acad Sci U S A 2001, 98:14084-14089.
15. Pan YX, Xu J, Bolan E, Moskowitz HS, Xu M, Pasternak GW: Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing. Mol Pharmacol 2005, 68:866-875.
16. Pan YX: Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol 2005, 24:736-750.
17. Pasternak DA, Pan L, Xu J, Yu R, Xu MM, Pasternak GW, Pan YX: Identification of three new alternatively spliced variants of the rat mu opioid receptor gene: dissociation of affinity and efficacy. J Neurochem 2004, 91:881-890.
18. Pan YX, Xu J, Mahurter L, Xu MM, Gilbert AK, Pasternak GW: Identification and characterization of two new human mu opioid receptor splice variants, hMOR-IO and hMOR-IX. Biochem Biophys Res Commun 2003, 301:1057-1061.
19. Pan L, Xu J, Yu R, Xu MM, Pan YX, Pasternak GW: Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm. Neuroscience 2005, 133:209-220.
20. Abbadie C, Pan YX, Pasternak GW: Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR-IC and MOR-I-like immunoreactivity: Evidence for region-specific processing. J Comp Neurol 2000, 419:244-256.
21. Abbadie C, Pan YX, Drake CT, Pasternak GW: Comparative immunhistochemical distributions of carboxy terminus epitopes from the mu opioid receptor splice variants MOR-ID, MOR-I and MOR-IC in the mouse and rat central nervous systems. Neuroscience 2000, 100:141-153.
22. Bolan EA, Pan YX, Pasternak GW: Functional analysis of MOR-I splice variants of the mouse mu opioid receptor gene Oprm. Synapse 2004, 51:11-18.
23. Abbadie C, Pasternak GW: Differential in vivo internalization of MOR-I and MOR-IC by morphine. Neuroreport 2001, 12:3069-3072.
24. Koch T, Schulz S, Schroder H, Wolf R, Raulf E, Hollt V: Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization. J Biol Chem 1998, 273:13652-13657.
25. Mayer P, Schulzeck S, Kraus J, Zimprich A, Hölt V: Promoter region and alternatively spliced exons of the rat m- opioid receptor gene. J Neurochem 1996, 66:2272-2278.
26. Ko JL, Minnerath SR, Loh HH: Dual promoters of mouse m-opioid receptor gene. Biochem Biophys Res Commun 1997, 234:351-357.
27. Liang Y, Carr LG: Transcription of the mouse mu-opioid receptor gene is regulated by two promoters. Brain Res 1997, 769:372-374.
28. Ko JL, Chen HC, Loh HH: Differential promoter usage of mouse mu-opioid receptor gene during development. Brain Res Mol Brain Res 2002, 104:184-193.
29. Hwang CK, Wu X, Wang G, Kim CS, Loh HH: Mouse mu opioid receptor distal promoter transcriptional regulation by SOX proteins. J Biol Chem 2003, 278:3742-3750.
30. Hwang CK, Kim CS, Choi HS, McKercher SR, Loh HH: Transcriptional regulation of mouse mu opioid receptor gene by PU.I. J Biol Chem 2004, 279:19764-19774.
31. Kim CS, Hwang CK, Choi HS, Song KY, Law PY, Wei LN, Loh HH: Neuron-restrictive silencer factor (NRSF) functions as a repressor in neuronal cells to regulate the mu opioid receptor gene. J Biol Chem 2004, 279:46464-46473.
32. Liang Y, Carr LG: Identification of an octamer-1 transcription factor binding site in the promoter of the mouse mu-opioid receptor gene. J Neurochem 1996, 67:1352-1359.
33. Ko JL, Loh HH: Single-stranded DNA-binding complex involved in transcriptional regulation of mouse m-opioid receptor gene. J Biol Chem 2001, 276:788-795.
34. Xu Y, Carr LG: Binding of Sp1/Sp3 to the proximal promoter of the hMOR gene is enhanced by DAMGO. Gene 2001, 274:119-128.
35. Rivera-Gines A, Cook RJ, Loh HH, Ko JL: Interplay of Sps and poly(C) binding protein 1 on the mu-opioid receptor gene expression. Biochem Biophys Res Commun 2006, 345:530-537.
36. Choi HS, Hwang CK, Kim CS, Song KY, Law PY, Wei LN, Loh HH: Transcriptional regulation of mouse mu opiold receptor gene: Sp3 isoforms (M1, M2) function as repressors in neuronal cells to regulate the mu opioid receptor gene. Mol Pharmacol 2005, 67:1674-1683.
37. Borner C, Woltje M, Hollt V, Kraus J: STAT6 transcription factor binding sites with mismatches within the canonical 5′-TTC...GAA-3′ motif involved in regulation of delta- and mu-opioid receptors. J Neurochem 2004, 91:1493-1500.
38. Ko JL, Loh HH: Poly C binding protein, a single-stranded DNA binding protein, regulates mouse mu-opioid receptor gene expression. J Neurochem 2005, 93:749-761.
39. Kim SS, Pandey KK, Choi HS, Kim SY, Law PY, Wei LN, Loh HH: Poly(C) binding protein family is a transcription factor in mu-opioid receptor gene expression. Mol Pharmacol 2005, 68:729-736.
40. Lee PW, Lee YM: Transcriptional regulation of mu opioid receptor gene by cAMP pathway. Mol Pharmacol 2003, 64:1410-1418.
41. Kraus J, Borner C, Giannini E, Hollt V: The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene. Mol Pharmacol 2003, 64:876-884.
42. Kraus J, Borner C, Giannini E, Hickfang K, Braun H, Mayer P, Hoehe MR, Ambrosch A, Konig W, Hollt V: Regulation of Mu opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J Biol Chem 2001, 276:43901-8.
43. Pan YX: Identification and characterization of a novel promoter of the mouse mu opioid receptor gene (Oprm) that generates eight splice variants. Gene 2002, 295:97-108.
44. Hu X, Cao S, Loh HH, Wei LN: Promoter activity of mouse kappa opioid receptor gene in transgenic mouse. Brain Res Mol Brain Res 1999, 69:35-43.
45. Kozak M: Regulation of translation in eukaryotic systems. Annu Rev Cell Biol 1992, 8:197-225.
46. Binder LI, Frankfurter A, Rebhun LI: The distribution of tau in the mammalian central nervous system. J Cell Biol 1985, 101:1371-1378.
47. Callahan CA, Yoshikawa S, Thomas JB: Tracing axons. Curr Opin Neurobiol 1998, 8:582-586.
48. Mombaerts P, Wang F, Dulac C, Chao SK, Nemes A, Mendelsohn M, Edmondson J, Axel R: Visualizing an olfactory sensory map. Cell 1996, 87:675-686.
49. Strotmann J, Conzelmann S, Beck A, Feinstein P, Breer H, Mombaerts P: Local permutations in the glomerular array of the mouse olfactory bulb. J Neurosci 2000, 20:6927-6938.
50. Georges F, Normand E, Bloch B, Le Moine C: Opioid receptor gene expression in the rat brain during ontogeny, with special reference to the mesostriatal system: an in situ hybridization study. Dev Brain Res 1998, 109:187-199.
51. Zhu YX, Hsu MS, Pintar JE: Developmental expression of the m, kappa, and d opioid receptor mRNAs in mouse. J Neurosci 1998, 18:2538-2549.
52. Rius RA, Barg J, Bem WT, Coscia CJ, Loh YP: The prenatal development profile of expression of opioid peptides and receptors in the mouse brain. Brain Res Dev Brain Res 1991, 58:237-241.
53. Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H, Watson SJ: Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study. J Comp Neurol 1994, 350:412-438.
54. Delfs JM, Kong H, Mestek A, Chen Y, Yu L, Reisine T, Chesselet MF: Expression of mu opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level. J Comp Neurol 1994, 345:46-68.
55. Kaufman DL, Keith DE Jr., Anton B, Tian J, Magendzo K, Newman D, Tran TH, Lee DS, Wen C, Xia YR, Lusis AJ, Evans CJ: Characterization of the murine m opioid receptor gene. J Biol Chem 1995, 270:15877-15883.
56. Ding YQ, Kaneko T, Nomura S, Mizuno N: Immunohistochemical localization of m-opioid receptors in the central nervous system of the rat. J Comp Neurol 1996, 367:375-402.
57. Mansour A, Fox CA, Burke S, Akil H, Watson SJ: Immunohistochemical localization of the cloned m opioid receptor in the rat CNS. J Chem Neuroanat 1995, 8:283-305.
58. Abbadie C, Pan YX, Pasternak GW: Immunohistochemical study of the expression of exonII-containing mu opioid receptor variants in mouse brain. Neuroscience 2004, 127:419-430.
59. Mansour A, Fox CA, Thompson RC, Akil H, Watson SJ: m-Opioid receptor mRNA expression in the rat CNS: comparison to m-receptor binding. Brain Res 1994, 643:245-265.
60. Mansour A, Fox CA, Akil H, Watson SJ: Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications. Trends Neurosci 1995, 18:22-29.
61. Mrkusich EM, Kivell BM, Miller JH, Day DJ: Abundant expression of mu and delta opioid receptor mRNA and protein in the cerebellum of the fetal, neonatal, and adult rat. Brain Res Dev Brain Res 2004, 148:213-222.
62. Zhang Y, Pan YX, Kolesnikov Y, Pasternak GW: Immunohistochemical labeling of the mu opioid receptor carboxy terminal splice variant mMOR-IB4 in the mouse central nervous system. Brain Res 2006, 1099:33-43.
63. Wittert G, Hope P, Pyle D: Tissue distribution of opioid receptor gene expression in the rat. Biochem Biophys Res Commun 1996, 218:877-881.
64. Hogan B, Costantini F, E. L: Manipulating the Mouse Embryo, A Laboratory Manual 2nd edition. Cold Spring Harbor Laboratory; 1994.
65. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.